1 Min Read
April 11 (Reuters) - XBRANE BIOPHARMA AB
* REG-XBRANE BIOPHARMA REPORTS POSITIVE IN-VIVO EFFICACY DATA ON SPHEROTIDE Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.